Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12609000923268
ACTRN12609000923268
Recruiting
未知

A pilot study to examine evidence of an immune response from acupuncture when administered to women undergoing a fresh in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle on the day of an embryo transfer

niversity of Western Sydney0 sites40 target enrollmentOctober 27, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsImmune System HealthReproductive HealthReproductive Health and Childbirth - Fertility including in vitro fertilisationInflammatory and Immune System - Normal development and function of the immune systemAlternative and Complementary Medicine - Other alternative and complementary medicine

Overview

Phase
未知
Intervention
Not specified
Conditions
Immune System Health
Sponsor
niversity of Western Sydney
Enrollment
40
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 27, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity of Western Sydney

Eligibility Criteria

Inclusion Criteria

  • •Women aged less than 43 years, undergoing a fresh IVF or ICSI cycle, with two unsuccessful ETs (includes previous cleavage or blastocyst stage transfers (fresh or frozen), of quality embryos deemed by the embryologist to have been suitable for freezing by standard criteria), and undergoing a stimulated cycle.

Exclusion Criteria

  • •Women undergoing a frozen ET, women less than 18 years, previous acupuncture during this IVF cycle, planning pre\-implantation genetic diagnosis, or receiving donor eggs.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A pilot study to investigate the immunological regulation of preeclampsiaO14Pre-eclampsia
DRKS00025864Carl von Ossietzky Universität Oldenburg/Klinikum Oldenburg; Universitätsklinik für Gynäkologie und Geburtshilfe200
Active, not recruiting
Phase 1
A prospective study to evaluate the immune response of UK infants receiving the 13-valent pneumococcal conjugate vaccine as part of their routine primary immunisation schedule at 2 and 4 months (code: P13UK) - P13UKPrevenar13 was introduced into the national childhood immunisation programme to prevent serious bacterial infections caused by the germ Streptococcus pneumonia, including meningitis, septicaemia and pneumonia.
EUCTR2010-023865-22-GBHealth Protection Agency
Completed
Phase 4
Responses to booster vaccinations in UK toddlers
ISRCTN84763401Health Protection Agency (UK)200
Active, not recruiting
Phase 1
A study investigating if markers for inflammation in the blood in patients with prostate cancer is affected by type of hormonal treatment received.Patients with advanced prostate cancer and pre-existing cardiovascular diseaseMedDRA version: 19.1Level: LLTClassification code 10036916Term: Prostate cancer stage DSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2016-004120-39-SERegion Skåne
Completed
Not Applicable
A study for evaluating the immune response by ingestion of fermented plant extractHealthy adult
JPRN-UMIN000052021EP Mediate Co., Ltd.36